✨PUBLISHED✨ Our scientific statement State of the Art of #ArtificialIntelligence in Clinical #Electrophysiology in 2025 We hope this new checklist helps both researchers & readers alike! Thank you @EmmaSvennberg & @DavidDuncker for the opportunity to contribute 🙏🏼 #EHRA2025

When all cardiologists from SoCal are on one flight. We got Prevention, imaging, EP, cardioonc, IC all covered. 🤣 🤣 🤣 #JoyofBeingACardiologist #GoodByeNOLA #WeWillbeBackForACC What a fantastic time at #AHA25 #AHA2025 Till next time ✌️ 👋

Ok you all, here is my take of the CLOSURE AF trial. On @theheartorg https://t.co/WppsVncNfi Teaser: this may herald cardiology's biggest medical reversal. Nonindustry funded, non-biased trial. LAAC clearly inferior to best medical therapy (usually DOAC, but 10% no AC.) #AHA25

Did you know GSPs are natural swimmers? They’re born to dive into life’s adventures 🌊🐾.

A real delight & so proud to see you on the podium & due recognition @PrashSanders @melissaemm1 @WongChrisX 👏👏 One of the ⭐️ @AHAScience #AHA25 Sessions @netta_doc 👏 & ⭐️Faculty @HeartBobH @NMHheartdoc @AndreaRussoEP

Fantastic job with the presentation @WongChrisX - very excited to share this good news that randomization to caffeinated coffee ⬇️#Afib, to have this presented as a LBCT @AHAScience, and published in @JAMANetwork Two caveats for all to consider lest we hear, “But you guys said

On behalf of senior author @gregorymmarcus and trial team: Honored to present the late-breaking clinical trial DECAF at #AHA25 today In contrast to conventional wisdom, coffee ☕️resulted in less AF #afib compared to abstinence! #SimPub @JAMA_current https://t.co/26K8Rn6jfU

Starting now in Main Event @AHAScience #AHA25 ⭐️⭐️⭐️⭐️ Panel for Cardiometabolic & #Lifestyle & Interventions for #Afib 1/n @HeartBobH @melissaemm1 Prof Han @PrashSanders @NMHheartdoc @WongChrisX ++

2/n @AHAScience #AHA25 Cardiometabolic & #Lifestyle & Interventions for #Afib Cant think of anyone more ⭐️ to provide the State of Art : Preventing #AFib than Prof @PrashSanders 👏👏 #cvPrev @thecsanz @DrDave01 @OzCvA @heartfoundation

KGLD allows investors to earn income from gold in a potentially more tax-efficient way than physical gold.

META‑AF – Metformin as an Adjunctive Therapy to Catheter Ablation of Atrial Fibrillation #METAAF #AHA25 🫀can metformin ⤵️ AF after ablation? 🫀excluded those with DM 🫀all received lifestyle counseling 🫀 disproportionately male 👎🏽 🫀weight loss in both groups about the same

❤️ #Prevention 🤝 #EPeeps Love seeing our star prevention colleagues in the front row of the EP #LBCT on Cardiometabolic and lifestyle interventions for #atrialfibrillation ! #AHA25 @pnatarajanmd @DrMarthaGulati

☕️ #AHA25 #DECAFTrial #DECAF Can eliminating coffee prevent AF recurrence? In DECAF, ~200 post-cardioversion pts were randomized to coffee abstinence vs continued coffee ☕️Conflicting data about coffee effect on arrhythmia: RCT of 200 pts s/p cardioversion of AF ☕️76% male 👎🏽 ☕️

Strong consistent message in ⭐️ @AHAScience #AHA25 #LBS.04!Cardiometabolic & #Lifestyle Interventions for #AFib strong evidence in these ⭐️presentations for 🔎 #lifestyle for #cvPrev @netta_doc @HeartBobH @melissaemm1 @PrashSanders @AndreaRussoEP @NMHheartdoc @WongChrisX

OCEAN trial: For AF patients with ≥1 risk factor post-catheter ablation, low-dose rivaroxaban showed similar rates of stroke/systemic embolism and major bleeding at 3 years compared to aspirin. #AHA25 View the slides here: https://t.co/FMhUbroiyp

. @SpeedyMorman doesn’t chase viral moments; he creates them. Calm, precise, and surgical, he makes space for honesty in an era allergic to nuance. Whether he’s sitting with rappers or whatever career Kim K is currently pursuing, he brings the same patience and the confidence of

DARE‑AF Trial (Dapagliflozin to Reduce Atrial Fibrillation Burden After Catheter Ablation) #AHA25 #DAREAF #LBCT ❓will SGLT2i reduce AF after ablation even in those who don’t need it for other indications? 🫀RCT of 200 pts, F/U 3m, excluded those with indication for SGLT2i-

Day 2 #LBCT in the EP world! Congratulations to @netta_doc for organizing and chairing this session! #AHA25

⭐️ #LBCT (LBS.04) Cardiometabolic and Lifestyle Interventions for #AtrialFibrillation starts now! #AHA25 with @HeartBobH @melissaemm1 @PrashSanders @AndreaRussoEP @NMHheartdoc @WongChrisX @adeshmukh and an all star team!

Get insights from Ulf Landmesser on the CLOSURE-AF Trial #ESCTVOntheRoad 🚍 at #AHA25

It's not about being ready someday, it's about being ready every day. Train at home with your own personal VR shooting simulator.

OCEAN just published in NEJM. In AF patients >1 yr after successful ablation, rivaroxaban did not reduce stroke/systemic embolism/new covert infarcts vs aspirin (0.31 vs 0.66 events/100 pt-yrs; P=0.28). Bleeding higher with rivaroxaban (1.6% vs 0.6%). https://t.co/AVZoOyhTqO

Presented at #AHA25: In patients with atrial fibrillation after successful ablation, rivaroxaban therapy did not lead to a significantly lower incidence of a composite of stroke, systemic embolism, or new covert embolic stroke than aspirin therapy. Full OCEAN trial results:

⁦⁦@EPeeps⁩ #AI of ablation data, #MRI and demographics improved prediction of post #ablation #AF. More work needed. #DECAAF ⁦@nmarrouche⁩ ⁦@Tulane⁩

BREAKING: In the latest #HRStv Journal Club, @DanielAlyeshmer and @atulverma_md break down the OCEAN trial, a late-breaking clinical trial from #AHA2025 exploring anticoagulation vs. low-dose aspirin after successful atrial fibrillation ablation. See the full interview here

🚨 JUST DROPPED: For all the talk about efficient energy to power AI data centers, the U.S. still has no serious plan to bring fusion energy to the grid. - Yet the physics has crossed its tipping point. - Billions in private capital are flowing. - Demand for firm, clean power